February 10, 2022
Back for its 21st meeting, The International Publication Planning Meeting (TIPPA) will be held as a virtual event on March 24-25. The conference will connect global stakeholders in biopharma, medical device/diagnostics, medical communication agencies, medical writers, and publishers for off-the-record discussion, networking, and idea exchange.
November 03, 2021
President Joe Biden and Congressional Democrats announced they reached a compromise plan for drug pricing that will reduce the costs of prescription drugs and insulin and finally allow Medicare to negotiate prices for high-cost prescription drugs.
October 12, 2021
But Americans generally have little confidence that the White House or Congress will recommend the right thing, a new poll shows.
July 29, 2021
Pharmaceutical companies routinely cover the cost of patient copays for expensive drugs under private insurance. A federal judge could make the practice legal for millions on Medicare as well.
July 26, 2021
The Kaiser Family Foundation (KFF) findings come as lawmakers in Congress consider establishing a hard cap on such spending.
July 15, 2021
Angela G. Huskey, PharmD, CPE, senior vice president and chief clinical officer at Millennium Health, joins us for the latest episode of RISE Radio, our podcast series that focuses on issues that impact our three communities: Quality & Revenue; Member Acquisition & Experience; and Social Determinants of Health.
January 06, 2021
The International Publication Planning Meeting (TIPPA) will be held as a virtual event on February 23-24. The conference will feature more than 25 industry experts who will explore the future of scientific and medical publications, the impact and engagement of digital innovations, and data integrity.
December 22, 2020
Within just a few days, the logistical barriers of the vaccine made by Pfizer and BioNTech were laid bare. Many officials now hang their hopes on Moderna, whose vaccine comes in containers of 100 doses, doesn’t require deep freezing and is good for 30 days from the time it’s shipped.
December 11, 2020
High stakes and big challenges await as the U.S. prepares to roll out vaccines against COVID-19, with front-line health care workers and vulnerable nursing home residents recommended as the top priority.
November 24, 2020
The Trump administration on Friday finalized the rebate rule, which excludes rebates on prescription drugs paid by manufacturers to pharmacy benefit managers and Part D plans from safe harbor protection under the Anti-Kickback Statute. The regulation is set to take effect Jan. 1, 2022 but is expected to face opposition.
January 14, 2020
Global stakeholders in biopharma, medical device/diagnostics, agencies, and publishers will convene at RISE’s 19th Annual International Publication Planning Meeting on Feb. 25-26 in San Diego.
April 26, 2019
Although the pharmacy profession has evolved over the last several decades, pharmacists remain an untapped resource within the health care industry. Indeed, health plans could see their star ratings improve if they work with pharmacists on innovative programs, says Victoria Losinski, PharmD, Ph.D., MBA, director of portfolio strategy and implementation, Blue Cross and Blue Shield of Minnesota, and a featured speaker at RISE’s upcoming Managed Care Pharmacy Innovation Summit. In this article, Losinski discusses strategies health plans can adopt to work with pharmacists to boost star ratings and health outcomes.
January 18, 2019
Val Injev, global medical publications lead for Alcon Laboratories, will lead a breakfast breakout session on evidence-based planning for medical device and diagnostic professionals at RISE’s 18th Annual International Publication Planning Meeting, February 20-21, in San Diego. RISE talked with Injev ahead of the conference about the importance of working with developers earlier in the process to ensure that high-quality studies about new products or diagnostics are published as soon as possible in peer-reviewed journals.
January 09, 2019
Patti Peeples, R.Ph., Ph.D., founder and CEO of HealthEconomics.Com, will be a keynote speaker at RISE’s 18th Annual International Publication Planning Meeting, February 20-21, in San Diego. In this exclusive interview, Peeples talks about the changes in health economics and outcomes research (HEOR) and real-world evidence (RWE) in the last three years and what they mean for the publication planning industry.